Company Overview
Snapshot
Founded in November 2019 by Dr. Or Peleg and Barry (Boris) Loevsky, LiteBC operates with 11–50 employees. The company has secured funding across 5 rounds from 3 investors.
Business overview
LiteBC is a Health Tech & Life Sciences company developing a noninvasive blood count device for real-time, in-vivo monitoring of blood cells. Its core technology utilizes advanced imaging and optical probes to analyze vital blood parameters, including white blood cells, red blood cells, differential counts, relative red blood cell volume, and hemoglobin. The device aims to transform complete blood counts into a simple, accessible, and continuous measurement, providing a rich diagnostic basis for the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is the current product stage of LiteBC's technology?
- LiteBC's product, HemoScope, is currently in the clinical trial stage, aiming to transform complete blood counts into a simple and accessible test.